Observational studyCancer medicine2026

Long-Term Survival Outcomes of Concurrent Chemoradiotherapy for Postoperative High-Risk Salivary Gland Carcinomas.

Shengjin Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.